Epoch Investment Partners Inc. Boosts Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Epoch Investment Partners Inc. grew its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 2.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 358,916 shares of the pharmaceutical company’s stock after purchasing an additional 10,059 shares during the period. Epoch […]

Related Keywords

Piper Sandler ,Ourania Tatsis ,Brucei Sachs ,Quest Partners ,Securities Exchange Commission ,Vertex Pharmaceuticals ,Arlington Trust Co ,Vertex Pharmaceuticals Incorporated ,Baystate Wealth Management ,Securities Inc ,Fortitude Family Office ,Vertex Pharmaceuticals Stock Performance ,Quarter For Vertex Pharmaceuticals ,Epoch Investment Partners Inc ,News Ratings For Vertex Pharmaceuticals Daily ,Epoch Investment Partners ,Free Report ,Investment Partners ,Family Office ,Wealth Management ,Pharmaceuticals Incorporated ,Get Free Report ,Director Bruce ,Vertex Pharmaceuticals Daily ,